Effects of Itopride on Gastric Motor and Sensory Functions in Healthy Volunteers
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
Itopride is a new compound that is already marketed in Japan and in some countries of Eastern
Europe under the name of Ganaton. It is used to treat symptoms associated with gastroparesis.
Due to inadequate gastric emptying, these patients often have symptoms of bloating, nausea
and vomiting following ingestion of a meal. This is a randomized, parallel group, two dose
double blind, placebo-controlled study evaluating the effects of itopride (100 mg and 200 mg
three times daily) and placebo on gastric motor and sensory functions in healthy volunteers.